Understanding Neuro-modulatory mechanism of Nasya karma with Dashamoola Ghrita in Migraine with CGRP biomarker- A case series
DOI:
https://doi.org/10.70066/jahm.v13i10.2328Keywords:
Migraine, CGRP, Neuro-modulation, Nasya karma, Dashmoola GhritaAbstract
Introduction: This case series explores the effect of Dashmoola Ghrita Marsha Nasya on migraine in relation to CGRP, a key neuromodulator in migraine pathophysiology. While CGRP has been extensively studied in modern medicine, its modulation through traditional Ayurvedic therapies remains underexplored. Clinical Findings: Three patients with episodic migraine presented with moderate to severe headaches, photophobia, and nausea. All had elevated MIDAS scores and serum CGRP levels, indicating significant disability and active neuroinflammatory response. Intervention: Patients underwent Marsha Nasya with Dashmoola Ghrita (8 bindu) for seven consecutive days. Outcomes: Post-treatment, patients demonstrated an average 34% reduction in MIDAS scores and an average 40% decrease in serum CGRP levels, indicating both symptomatic relief and biochemical parameters. Conclusion: Dashmoola Ghrita Marsha Nasya may exert a neuro-modulatory effect on CGRP and improve clinical outcomes in migraine. These findings suggest the potential role of integrating Nasya therapy with biomarker-based evaluation in the management of migraine.
References
World Health Organization. Parkinson disease: Key facts [Internet]. Geneva: WHO; 2023 [cited 2025 Nov 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/headache-disorders
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210. https://doi.org/10.1111/j.1468-2982.2007.01288.x
Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol. 2004;55(1):27–36.rstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol. 2004 Jan;55(1):27–36. https://doi.org/10.1002/ana.10785
Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183–7. https://doi.org/10.1002/ana.410280213
Van Dongen RM, Zielman R, Noga M, Dekkers OM, Hankemeier T, van den Maagdenberg AM, Terwindt GM, Ferrari MD. Migraine biomarkers in cerebrospinal fluid: a systematic review and meta-analysis. Cephalalgia. 2017;37(1):49–63. https://doi.org/10.1177/0333102415625614
Bellamy JL, Cady RK, Durham PL. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache. 2006;46(1):24–33. https://doi.org/10.1111/j.1526-4610.2006.00294.x
Iyengar S, Johnson KW, Ossipov MH, Aurora SK. CGRP and the trigeminal system in migraine. Headache. 2019;59(5):659–81 https://doi.org/10.1111/head.13529
Shastri A, editor. Sushruta Samhita of Sushruta with Ayurveda Tatva Sandipika Hindi Commentary. Chapter 25, verse 15, 165, Reprint ed. Varanasi: Chaukhambha Sanskrit Sansthana; 2011.
Sharangadhara. Sharangadhara Samhita. In: Tripathi B, editor. Nasyavidhi Adhyaya, Uttar khanda,chapter 8, verse 25,231, Varanasi: Chaukhambha Prakashan; 2011
Vagbhata. Ashtanga Hridaya. In: Arunadatta, commentator. Sarvangasundara. Sutra Sthana, Chapter 20, verse 1, 287, Varanasi: Chaukhambha Sanskrit Series Office; 2009.
Tiwari R, Sharma S, Sahu S, Mishra K. A conceptual and critical study of “Nasa hi sirso dwaram” w.s.r. to Nasya Karma. World J Pharm Med Res. 2022;8(8):141–5 https://www.wjpmr.com/download/article/99072022/1659164698.pdf
Rajput A, Pingale P, Dhapte-Pawar V. Nasal delivery of neurotherapeutics via nanocarriers: facets, aspects, and prospects. Front Pharmacol. 2022;13:979682. https://doi.org/10.3389/fphar.2022.979682
Urs KL, Sweta KM. Conceptual understanding of anti-inflammatory effects of Dashamoola with relevant modern effects: a critical study. J Ayurveda Integr Med Sci. 2022 [cited 2025 Nov 6]. https://www.jaims.in/jaims/article/view/2178
Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J, Cipolla-Neto J, Silberstein SD, Zukerman E. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001;71(6):747–51. https://doi.org/10.1136/jnnp.71.6.747
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Himani Binji, Dr. Vishnu U , Dr. Kadamabri P B, Dr. Vishnu Raj, Dr. K P Namboothiri
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
